(RDY) Dr. Reddy’s - Performance 3.3% in 12m
RDY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
28.07%
#39 in Peer-Group
Rel. Strength
42.61%
#4413 in Stock-Universe
Total Return 12m
3.30%
#76 in Peer-Group
Total Return 5y
69.92%
#26 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 19.4 |
| P/E Forward | 19.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 16.84 USD |
| 52 Week Low | 12.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 42.14 |
| Buy/Sell Signal +-5 | 0.05 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RDY (3.3%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.29% | 129% | 303% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.47% | 17.1% | 81% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-0.11% | -15.2% | 392% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.04% | 3.99% | 53.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.53% | 3.01% | 48.7% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-9.28% | -9.26% | 107% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.63% | -7.9% | 44.7% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| IPN PA Ipsen |
-1.44% | -6.07% | 39.8% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: RDY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RDY
| Total Return (including Dividends) | RDY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -3.52% | 0.63% | 3.81% |
| 3 Months | 19.87% | 0.40% | 23.42% |
| 12 Months | 3.30% | -5.27% | 13.17% |
| 5 Years | 69.92% | 44.05% | 112.04% |
| Trend Score (consistency of price movement) | RDY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -78.7% | 29.2% | 81% |
| 3 Months | 90.3% | -24.1% | 97.3% |
| 12 Months | -58.7% | -75.6% | 45.1% |
| 5 Years | 61.5% | 87.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th42.50 | -4.13% | -7.06% |
| 3 Month | %th57.00 | 19.40% | -2.88% |
| 12 Month | %th62.00 | 9.05% | -8.72% |
| 5 Years | %th86.50 | 17.96% | -19.86% |
FAQs
Does Dr. Reddy’s (RDY) outperform the market?
Yes,
over the last 12 months RDY made 3.30%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.27%.
Over the last 3 months RDY made 19.87%, while XLV made 0.40%.
Performance Comparison RDY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RDY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.1% | -7.3% | -9.9% | -10% |
| US NASDAQ 100 | QQQ | 0.3% | -7.7% | -11.2% | -8% |
| German DAX 40 | DAX | -0.2% | -3.1% | -21.6% | -26% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.1% | -6.2% | -11.9% | -17% |
| Hongkong Hang Seng | HSI | 0.5% | -6.1% | -28.2% | -35% |
| India NIFTY 50 | INDA | 0.9% | -3.7% | -9.4% | 5% |
| Brasil Bovespa | EWZ | 1.2% | -9% | -29.5% | -4% |
RDY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.7% | -7.2% | -13.7% | -21% |
| Consumer Discretionary | XLY | -0.2% | -5.9% | -2.5% | -13% |
| Consumer Staples | XLP | -1.1% | -4.9% | -11.4% | -6% |
| Energy | XLE | -1.3% | -7.5% | -3.4% | 4% |
| Financial | XLF | -0.3% | -7.2% | -13.5% | -26% |
| Health Care | XLV | 0.7% | -4.2% | -0.8% | 9% |
| Industrial | XLI | -0.6% | -6.7% | -17% | -21% |
| Materials | XLB | -2.7% | -6.4% | -13% | -1% |
| Real Estate | XLRE | 0.2% | -3.5% | -9.1% | -8% |
| Technology | XLK | -0.3% | -10.1% | -13.1% | -6% |
| Utilities | XLU | -0.1% | -5.9% | -13.2% | -20% |
| Aerospace & Defense | XAR | 0.9% | -8.1% | -29.3% | -46% |
| Biotech | XBI | -0.5% | -2.7% | 6.2% | 14% |
| Homebuilder | XHB | -2.3% | -8.8% | -2.2% | 1% |
| Retail | XRT | -3.4% | -5.3% | -5% | -7% |
RDY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.3% | -9.67% | -1.61% | 8% |
| Natural Gas | UNG | 1.4% | 5.2% | 1.7% | 8% |
| Gold | GLD | -0.5% | -3.8% | -29.5% | -38% |
| Silver | SLV | -1.6% | -3.6% | -26.1% | -16% |
| Copper | CPER | 1.9% | -5.1% | -22.6% | -6% |
RDY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.4% | -4.7% | -6.2% | 6% |
| iShares High Yield Corp. Bond | HYG | 0.5% | -5% | -8.3% | -6% |